Combined use of (18)F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
Pengel, K.E., Koolen, B.B., Loo, C.E., Vogel, W.V., Wesseling, J., Lips, E.H., Rutgers, E.J.Th., Valdes Olmos, R.A., Vrancken Peeters, M.J., Rodenhuis, S, Gilhuijs, K.G.A.
DOI: https://doi.org/10.1007/s00259-014-2770-2
European Journal of Nuclear Medicine and Molecular Imaging 41 (8), p. 1515-1524